Call For Proposals
Call for Research Grant Proposals: Advancing Medulloblastoma Research
Funding Organizations: The CURE Collaborative (Charities United for Research Excellence)
Bibi Fund, Morgan Adams Foundation, Solving Kids’ Cancer, Ty Louis Foundation
Grant Title: CURE-MB: 2026 Medulloblastoma Breakthrough Catalyst Grants
Letter of Intent (LOI) Deadline: March 1, 2026
Full Proposal Deadline for Invited LOIs: May 1, 2026
Grant Amount: Up to $150,000 per award
Number of Awards: 2
Overview
The CURE Collaborative (Charities United for Research Excellence) invites Letters of Intent for bold, high-risk, high-reward projects that can rapidly advance understanding and treatment of medulloblastoma. We encourage a wide spectrum of proposals that will improve outcomes for medulloblastoma, including those designed to generate pilot/seed data that will position investigators/teams for larger external funding.
Scope of Funding
We welcome proposals that include (but are not limited to):
- Biology & mechanisms: molecular, genetic, and epigenetic drivers of medulloblastoma pathogenesis.
- Therapeutic innovation: novel targeted agents, immunotherapies, and approaches to personalization/precision medicine.
- Translational impact: studies that bridge laboratory discoveries to clear clinical application pathways.
Eligibility Criteria
- Researchers worldwide affiliated with accredited academic institutions, hospitals, or research organizations.
- Multidisciplinary and collaborative projects are encouraged.
- Investigators at all stages of their career are eligible to apply.
- Preliminary data is not a pre-requisite.
- Clinical trials are not eligible for funding.
- Investigators may submit more than one LOI.
Application Process
Interested applicants must submit:
- Letter of Intent (max 1 page): objectives/aims, brief methodology, expected outcomes, and a concise innovation paragraph (Times New Roman, 11pt, 1” margins). An additional page of pertinent references is permitted. Please include a separate cover page with proposal title and name of investigator and submit as a single PDF file with the document file labelled with the principal investigator name. LOI should be submitted to grants@solvingkidscancer.org by 11:59 pm ET March 1, 2026
- Following LOI review, selected applicants will be invited to submit a full proposal by May 1, 2026.
Evaluation Criteria
Proposals will be evaluated based on the following:
- Scientific merit and originality/innovation
- Feasibility and methodological rigor
- Investigator qualifications and track record
- Relevance to medulloblastoma
Potential impact, including but not limited to the likelihood of leveraging larger funding opportunities
Funding and Reporting Requirements
- Up to $150,000 total per award, disbursed over 2 years (milestones in 2026 and 2027).
- Progress and financial reports are required prior to the second-year milestone and at project completion.
- Successful projects may be considered for renewal or supplemental funding based on results.
- No indirect costs or PI (principal investigator) salary are permitted.
Submission and Contact Information
- LOIs must be submitted electronically to grants@solvingkidscancer.org by March 1, 2026.
- Invited full proposals are due May 1, 2026.
- For questions, contact Donna Ludwinski at donna@solvingkidscancer.org
Nonprofits Collaborate on funding research for rare pediatric brain tumors
Childhood Cancer Awareness Month: Lace Up for Kids 2025
Ways to Give Back During the Holidays
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need. From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story
Lace Up for Kids and fight Childhood Cancer!
Smithtown Goes Gold for Childhood Cancer Awareness Month!
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
